Clinical Trial Update: Bone Marrow-Derived Autologous Stem Cells for the Treatment of Duchenne Muscular Dystrophy [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial investigating autologous bone marrow–derived stem cells for Duchenne muscular dystrophy; current status not provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duchenne Muscular Dystrophy

Drugs mentioned

• Bone marrow-derived autologous stem cells

Snippet

Sponsor: Stem Cells Arabia | Conditions: Duchenne Muscular Dystrophy | Phase 1, Phase 2 | Status: UNKNOWN